溴羟喹啉 T0701

Product Introduction
Bioactivity


英文名: Broxyquinoline

描述: Broxyquinoline (5,7-Dibromo-8-hydroxyquinoline) 是一种有效的发热伴血小板减少综合症病毒 (SFTSV) 抑制剂，IC50为 5.8 µM。Broxyquinoline 是一种抗原虫药。

体内活性: Broxyquinoline抑制HIF-1α的脯氨酰和天冬酰胺羟基化的体外活性。Broxyquinoline抑制CpACBP1与NBD-palmitoyl-CoA的结合。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 14 mg/mL (46.2 mM)


关键字: Inhibitor | Parasite | inhibit | Broxyquinoline

相关产品: Valrubicin | Delafloxacin | Acetylazide | Dirithromycin | Kanamycin A | Cefazedone | Ornidazole | 2,5-Dihydroxy-1,4-benzoquinone | Doxycycline hydrochloride | Kanamycin sulfate

相关库: Drug Repurposing Compound Library | Approved Drug Library | Antibiotics Library | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compounds Library Max | Inhibitor Library | Anti-Parasitic Compound Library | NO PAINS Compound Library | Bioactive Compound Library | Anti-Infection Compound Library

溴羟喹啉 T0701信息由TargetMol中国为您提供，如您想了解更多关于溴羟喹啉 T0701报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途